CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Non Operating Interest Expenses (2012 - 2016)

Updated

CNBX Pharmaceuticals (CNBX) reported Non Operating Interest Expenses of $1,586 for fiscal Q2 2016 (quarter ended Feb 29, 2016), up 103.3% from the prior quarter.

Analysis

CNBX Pharmaceuticals Inc. (CNBX) Non Operating Interest Expenses (2012 - 2016) Analysis & Trends

Over the twelve months ended Feb 29, 2016, CNBX Pharmaceuticals' Non Operating Interest Expenses came in at $2,366, up 174.2% year-over-year; for FY2015 (ended Aug 31, 2015), it came in at $3,026, up 211.6% from FY2014.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of 126.3% (FY2010 to FY2015).
  • By fiscal year, Non Operating Interest Expenses came in at $971.00 in FY2014 (+442.5%), $179.00 in FY2013 and $13.00 in FY2012.
  • The fiscal Q2 2016 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to fiscal Q1 2013.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Feb 29, 2016 1,586.00
Nov 30, 2015 780.00
Aug 31, 2014 847.00
May 31, 2014 16.00
Feb 28, 2014 36.00
Nov 30, 2013 72.00
Aug 31, 2013 92.00
May 31, 2013 62.00
Feb 28, 2013 -11.00
Nov 30, 2012 37.00
API Access

CNBX Pharmaceuticals Inc. Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CNBX&period=max&api_key=YOUR_API_KEY